Heterogeneous expression of long noncoding RNA RP11-109D20.2: Insights into regulatory gene expression roles in colon cancer
Colorectal cancer is one of the deadliest cancers worldwide, which can be prevented and even cured by early diagnosis and more efficient treatment modalities. Comprehensive transcriptional analysis has highlighted the importance of lncRNAs in CRC tumorigenesis. In this study, we identified co-expressed lncRNA networks based on public RNA sequencing data for biomarker prediction in CRC and then verified the best candidate experimentally.
Publicly available RNA-sequencing data (BioProject PRJEB27536) of CRC samples and normal adjacent tissues were reanalyzed using the DESeq2 package in R to find differentially expressed lncRNAs. Pathway enrichment and gene network analysis were accomplished using GSEA and WGCNA to identify potential functions of lncRNAs with possible roles in tumorigenesis pathways. Subsequently, the expression of RP11-109D20.2 (lnc-Duox2-1:1) was assessed in fresh/frozen tissues obtained from 46 CRC patients by quantitative RT-PCR.
A total of 17939 DElncRNAs were identified between CRC and normal tissues via bioinformatics analyses. A significant up-regulation of RP11-109D20.2 (48%) was observed in CRC samples. Functional enrichment analysis showed that RP11-109D20.2 was mainly related to pathways like phosphoric ester hydrolase, oxidoreductase, phosphoric diester hydrolase, and cyclic-nucleotide phosphodiester activities. Moreover, elevated expression of DUOX2 in tumors with high levels of RP11-109D20.2 suggests a link between these genes.
Our data revealed that RP11-109D20.2 may have a considerable role in CRC progression. However, further functional analyses are essential to evaluate the probable role of RP11-109D20.2 as a potential diagnostic marker and its potential role in the dysregulation of cyclic nucleotide phosphodiesterase genes in CRC.
-
Toxicity comparison of two nanocarriers, magnetic mesoporous silica and polyoxometalate, using in vitro methods in PC-3 cells
Elaheh Valizadehkakhki, Farrokhzad Mohammadi Zonoz *, Amir Shokouh Saljooghi, , Zahra Sadat Ahmadi Koopaee
Journal of Cellular, Molecular and Biomedical Reports, Summer 2025 -
Developing A General Checklist for The Effective Administration of Extracellular Vesicles in Biomedical and Clinical Research
Azadeh Haghighitalab, Mahboubeh Kazemi Noughabi, Halimeh Hassanzadeh, Faezeh Shekari, Maryam Moghadam Matin, Rebecca Lim, Hamidreza Bidkhori, Ahmadreza Bahrami *
Cell Journal (Yakhteh), Nov 2024 -
Evaluation of the Expression Level of Some Coding and Non-coding Genes in Breast Cancer Samples Based on Bioinformatics and Laboratory Studies
Elmira Rostamnejad, Ronak Rashidi, Zohreh Akbari, Mazaher Maghsoudloo, Mehrdad Hashemi, , Maliheh Entezari, Majid Sadeghizadeh
International Journal of Cancer Management, Dec 2024 -
TRIM14 and TRIM29 as potential tumor markers for breast cancer diagnosis
Mohammadreza Roshanazadeh, Mojtaba Rashidi, Arash Sanaei, Hossein Azizi Dariuni, , Maryam Adelipour*
Iranian Journal of Breast Diseases,